Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,700
Closed -$1.03M 4430
2025
Q1
$1.03M Buy
+15,700
New +$1.06M ﹤0.01% 2630
2024
Q4
Sell
-10,000
Closed -$835K 4970
2024
Q3
$835K Buy
+10,000
New +$666K ﹤0.01% 2743
2024
Q1
Sell
-5,500
Closed -$305K 3947
2023
Q4
$305K Buy
+5,500
New +$248K ﹤0.01% 3343

Other funds holding ACLX

Squarepoint's ACLX Position: Q1 2026 in Review

Squarepoint reduced its Arcellx (ACLX) stake by 46% in Q1 2026, selling an estimated $2.01M and leaving 27,145 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Squarepoint first reported a position in ACLX in Q1 2022 and has held it in 11 quarters since. The position peaked at $8.42M in Q1 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Squarepoint held 27,145 shares of Arcellx worth $3.12M as of Q1 2026.
  • Squarepoint sold 22,730 Arcellx shares in Q1 2026, an estimated $2.01M.
  • Arcellx made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1860 holding.
  • Squarepoint first reported a position in Arcellx in Q1 2022 and has held it in 11 quarters since.
  • Squarepoint's Arcellx position peaked at $8.42M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.